REAL TIME NET WORTH — as of 5/8/17
$1.34 B
- Fang Tonghua chairs ZBD Pharmaceutical, a pharmaceuticals supplier.
- Fang’s ZBD listed at the Shanghai Stock Exchange in April 2015 after raising $240 million in an IPO.
- ZBD’s main products are Chinese medicines for cardiovascular disease.
Source: